Gara Jalqabaatti › Dhibee Autoimmune › Texas › Houston
Qorannoo klinikaalii Dhibee Autoimmune Houston, TX keessatti
Qorannoo 21 Dhibee Autoimmune f Houston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Namoota walitti qabaa jiraSadarkaa 1
- UT MD Anderson Cancer Center, Houston
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Namoota walitti qabaa jiraSadarkaa 2
- MD Anderson Cancer Center, Houston
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Namoota walitti qabaa jiraSadarkaa 3
- Abigail Neiman MD PA, Houston
- Novel Research LLC, Bellaire · Miili 7 fagaatti
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Namoota walitti qabaa jiraSadarkaa 2
- Jade Clinical Site, Houston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 3
- Baylor College of Medicine, Houston
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Namoota walitti qabaa jiraSadarkaa 2
- University of Texas - Houston, Houston
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Namoota walitti qabaa jiraSadarkaa 2/3
- Houston Methodist Hospital - Accepting Adult Patients, Houston
- University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 3
- Baylor College of Medicine, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, Houston
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Texas MD Anderson Cancer Center, Houston
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Namoota walitti qabaa jiraSadarkaa 3
- Nephro Asso North Illinois Indiana, Houston
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Namoota walitti qabaa jiraSadarkaa 1/2
- Baylor College of Medicine Neurology Department, Houston
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Namoota walitti qabaa jiraSadarkaa 3
- Texas Children's Hospital/ Baylor College of Medicine, Houston
Study of BHV-1300 in Graves' Disease
Namoota walitti qabaa jiraSadarkaa 1
- Site-106, Houston
- Site-101, Houston
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Namoota walitti qabaa jiraSadarkaa 3
- Site Number - 1057, Houston
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Namoota walitti qabaa jiraSadarkaa 2/3
- Houston Methodist Hospital, Houston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital - Baylor Medical Center, Houston
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Namoota walitti qabaa jiraSadarkaa 1/2
- MD Anderson Texas Medical Center, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Namoota walitti qabaa jiraQorannoo ilaalaa
- M D Anderson Cancer Center, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Namoota walitti qabaa jiraSadarkaa 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Namoota walitti qabaa jiraSadarkaa 1
- Houston Methodist Hospital, Houston
Qorannoo Dhibee Autoimmune magaalota biroo keessatti
- Washington, DCQorannoo 19
- New York City, NYQorannoo 19
- Philadelphia, PAQorannoo 16
- Durham, NCQorannoo 15
- Boston, MAQorannoo 13
- Chicago, ILQorannoo 12
- Los Angeles, CAQorannoo 12
- Dallas, TXQorannoo 9
- Atlanta, GAQorannoo 8
- Portland, ORQorannoo 8
- Milwaukee, WIQorannoo 8
- Cleveland, OHQorannoo 8
Qorannoo biroo Houston keessatti
- Kansara Qara'a Non-Small CellQorannoo 145
- Saree OljooQorannoo 126
- Saree (Gosoota Hunda)Qorannoo 121
- Kansara MetastatikiiQorannoo 104
- Kansarii ColorectalQorannoo 102
- Kansarii OvariiQorannoo 89
- Leukemia Myeloidii HamaaQorannoo 85
- Dhibee QaraQorannoo 78
- Kansarii ProstateQorannoo 76
- Kansa EndometiriyaaliiQorannoo 68
- Kansarii PancreasQorannoo 61
- MelanomaQorannoo 59
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.